A peptide vaccine administered transcutaneously together with cholera toxin elicits potent neutralising anti-FMDV antibody responses
- 8 April 2005
- journal article
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 104 (3-4) , 273-280
- https://doi.org/10.1016/j.vetimm.2004.12.008
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Modulation of immune responses with transcutaneously deliverable adjuvantsVaccine, 2004
- Transcutaneous Immunization with Tetanus Toxoid and Mutants ofEscherichia coliHeat‐Labile Enterotoxin as Adjuvants Elicits Strong Protective Antibody ResponsesThe Journal of Infectious Diseases, 2003
- Intranasal Immunization of Guinea Pigs with an Immunodominant Foot-and-Mouth Disease Virus Peptide Conjugate Induces Mucosal and Humoral Antibodies and Protection against ChallengeJournal of Virology, 2003
- Immunostimulant Patch Containing Heat-Labile Enterotoxin fromEscherichia coliEnhances Immune Responses to Injected Influenza Virus Vaccine through Activation of Skin Dendritic CellsJournal of Virology, 2003
- Safety and Immunogenicity of a Prototype EnterotoxigenicEscherichia coliVaccine Administered TranscutaneouslyInfection and Immunity, 2002
- Immunization onto bare skin with synthetic peptides: immunomodulation with a CpG‐containing oligodeoxynucleotide and effective priming of influenza virus‐specific CD4+ T cellsImmunology, 2002
- Transcutaneous Immunization with Bacterial ADP-Ribosylating Exotoxins, Subunits, and Unrelated AdjuvantsInfection and Immunity, 2000
- Protection of swine from foot-and-mouth disease with one dose of an all-D retro peptideVaccine, 1999
- New approaches to vaccination against foot-and-mouth diseaseVaccine, 1992
- Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequenceNature, 1982